Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.

Signify Premium Insight: Futures for the Faithful – Vendor Sentiment Index Q3

Signify Premium Insights Subscription Required

13th October 2022 – There are many challenges ahead for vendors looking to capitalise on the evolving medical imaging AI market, however, as shown in Signify Research’s Vendor Sentiment Index, there are also reasons for confidence.

Signify Premium Insight: Neusoft Medical to Float on United Imaging’s Rising Tide

Signify Premium Insights Subscription Required

11th October 2022 – Neusoft has announced that after three unsuccessful attempts, it is yet again planning to list publicly. Does it offer a unique proposition, or is the vendor just clinging on to its rivals’ coattails? This Insight explores its opportunity

AliveCor – Turning Up The Heat in Diagnostic Cardiology

In recent years AliveCor has been actively developing its solutions and relationships across the digital cardiac diagnosis space. Last month it announced a collaboration with Biotronik to integrate its KardiaMobile 6L and KardiaMobile Card ECG technology with Biotronik’s BIOMONITOR Injectable Cardiac Monitor.

Signify Premium Insight: Amazon’s Multi-Billion Dollar Care Conundrum

Signify Premium Insights Subscription Required

7th October 2022 – Amazon has long harboured ambitions on the healthcare space, will the acquisition of One Medical help the tech firm realise this dream.

Signify Premium Insight: What Intelerad Hopes to Make with Life Image Acquisition

Signify Premium Insights Subscription Required

6th October 2022 – Intelerad continues its acquisition streak with the purchase of image exchange vendor Life Image. The move further bolsters Intelerad’s strong breadth of capability, but, should the vendor have focused on other priorities?